메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
김지현 (국립암센터) 이유미 (부경대학교) 김다영 (Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea) 김시내 (Biostatistics Collaboration Team, Research Core Center, National Cancer Center, Goyang, Korea) 서상수 (국립암센터) 강석범 (국림암센터) 박상윤 (국립암센터) 임명철 (국립암센터)
저널정보
대한부인종양학회 Journal of Gynecologic Oncology Journal of Gynecologic Oncology Vol.35 No.1
발행연도
2024.1
수록면
1 - 12 (12page)
DOI
https://doi.org/10.3802/jgo.2024.35.e3

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objective: To identif y the adherence rate to poly (ADP-ribose) polymerase (PARP) inhibitorsand identif y factors contributing to the deterioration of adherence at our institution. Methods: The adherence rate to PARP inhibitors was calculated using self-reported Adherenceto Refills and Medications Scale questionnaires from a cross-sectional sur vey. Multivariablelogistic regression analysis was performed to identif y the factors that affected adherence. Results: Of the 131 respondents, 32 (24.4%) showed non-adherence to PARP inhibitors. In the multivariable logistic regression analysis, unemployed or retired status (odds ratio[OR]=4.878; 95% confidence inter val [CI]=1.528–15.572; p=0.008), patients receivingniraparib (OR=3.387; 95% CI=1.283–8.940; p=0.014), and a lower score on the quality-of-life assessment (EORTC-QLQ-OV28), which reflects a better quality of life (QOC) with alower symptom burden (OR=1.056; 95% CI=1.027–1.086; p<0.001) were associated with highadherence to PARP inhibitors. Conclusion: Approximately one-fourth of patients with ovarian cancer are non-adherent toPARP inhibitors as maintenance treatment for newly diagnosed advanced ovarian cancer. Theoccupational status, type of PARP inhibitor, and QOC may affect adherence to PARP inhibitors.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

최근 본 자료

전체보기

댓글(0)

0